Originally published as JCO Early Release 10.1200/JCO.2005.08.001 on September 12 2005
Journal of Clinical Oncology, Vol 23, No 30 (October 20), 2005: pp. 7703-7720
© 2005 American Society of Clinical Oncology.
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
Gary H. Lyman,
Armando E. Giuliano,
Mark R. Somerfield,
Al B. Benson, III,
Diane C. Bodurka,
Harold J. Burstein,
Alistair J. Cochran,
Hiram S. Cody, III,
Stephen B. Edge,
Sharon Galper,
James A. Hayman,
Theodore Y. Kim,
Cheryl L. Perkins,
Donald A. Podoloff,
Visa Haran Sivasubramaniam,
Roderick R. Turner,
Richard Wahl,
Donald L. Weaver,
Antonio C. Wolff,
Eric P. Winer
From the University of Rochester School of Medicine and Dentistry, Rochester, NY; John Wayne Cancer Institute, Santa Monica, CA; Northwestern University, Evanston, IL; The University of Texas M.D. Anderson Cancer Center, Houston, TX; Dana-Farber Cancer Institute, Boston, MA; David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA; Memorial Sloan-Kettering Cancer Center, New York, NY; Roswell Park Cancer Institute, Buffalo, NY; Brigham and Women's Hospital, Boston, MA; University of Michigan, Ann Arbor, MI; Tufts-New England Medical Center, Boston, MA; the Susan G. Komen Breast Cancer Foundation, Dallas, TX; The University of Texas M.D. Anderson Cancer Center, Houston, TX; University of Kentucky, Lexington, KY; St John's Health Center, Santa Monica, CA; The Johns Hopkins University, Baltimore, MD; University of Vermont College of Medicine, Burlington, VT; Dana-Farber Cancer Institute, Boston, MA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD
PURPOSE: To develop a guideline for the use of sentinel node biopsy (SNB) in early stage breast cancer.
METHODS: An American Society of Clinical Oncology (ASCO) Expert Panel conducted a systematic review of the literature available through February 2004 on the use of SNB in early-stage breast cancer. The panel developed a guideline for clinicians and patients regarding the appropriate use of a sentinel lymph node identification and sampling procedure from hereon referred to as SNB. The guideline was reviewed by selected experts in the field and the ASCO Health Services Committee and was approved by the ASCO Board of Directors.
RESULTS: The literature review identified one published prospective randomized controlled trial in which SNB was compared with axillary lymph node dissection (ALND), four limited meta-analyses, and 69 published single-institution and multicenter trials in which the test performance of SNB was evaluated with respect to the results of ALND (completion axillary dissection). There are currently no data on the effect of SLN biopsy on long-term survival of patients with breast cancer. However, a review of the available evidence demonstrates that, when performed by experienced clinicians, SNB appears to be a safe and acceptably accurate method for identifying early-stage breast cancer without involvement of the axillary lymph nodes.
CONCLUSION: SNB is an appropriate initial alternative to routine staging ALND for patients with early-stage breast cancer with clinically negative axillary nodes. Completion ALND remains standard treatment for patients with axillary metastases identified on SNB. Appropriately identified patients with negative results of SNB, when done under the direction of an experienced surgeon, need not have completion ALND. Isolated cancer cells detected by pathologic examination of the SLN with use of specialized techniques are currently of unknown clinical significance. Although such specialized techniques are often used, they are not a required part of SLN evaluation for breast cancer at this time. Data suggest that SNB is associated with less morbidity than ALND, but the comparative effects of these two approaches on tumor recurrence or patient survival are unknown.
Authors' disclosures of potential conflicts of interest are found at the end of this article.
Address reprint requests to American Society of Clinical Oncology, Cancer Policy and Clinical Affairs, 1900 Duke St, Suite 200, Alexandria, VA 22314; e-mail: guidelines@asco.org.

CiteULike Complore Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. de Boer, C. H.M. van Deurzen, J. A.A.M. van Dijck, G. F. Borm, P. J. van Diest, E. M.M. Adang, J. W.R. Nortier, E. J.T. Rutgers, C. Seynaeve, M. B.E. Menke-Pluymers, et al.
Micrometastases or Isolated Tumor Cells and the Outcome of Breast Cancer
N. Engl. J. Med.,
August 13, 2009;
361(7):
653 - 663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Y. Bilimoria, D. J. Bentrem, N. M. Hansen, K. P. Bethke, A. W. Rademaker, C. Y. Ko, D. P. Winchester, and D. J. Winchester
Comparison of Sentinel Lymph Node Biopsy Alone and Completion Axillary Lymph Node Dissection for Node-Positive Breast Cancer
J. Clin. Oncol.,
June 20, 2009;
27(18):
2946 - 2953.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Coutant, C. Olivier, E. Lambaudie, E. Fondrinier, F. Marchal, F. Guillemin, N. Seince, V. Thomas, J. Leveque, E. Barranger, et al.
Comparison of Models to Predict Nonsentinel Lymph Node Status in Breast Cancer Patients With Metastatic Sentinel Lymph Nodes: A Prospective Multicenter Study
J. Clin. Oncol.,
June 10, 2009;
27(17):
2800 - 2808.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Gadd
Sentinel lymph node biopsy for staging early breast cancer: minimizing the trade-off by maximizing the accuracy
Ann. Onc.,
June 1, 2009;
20(6):
973 - 975.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Canavese, A. Catturich, C. Vecchio, D. Tomei, M. Gipponi, G. Villa, F. Carli, P. Bruzzi, and B. Dozin
Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial
Ann. Onc.,
June 1, 2009;
20(6):
1001 - 1007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Lee, E. L. Rosen, and D. A. Mankoff
The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 1--Overview, Detection, and Staging
J. Nucl. Med.,
April 1, 2009;
50(4):
569 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-M. Classe, V. Bordes, L. Campion, H. Mignotte, F. Dravet, J. Leveque, C. Sagan, P. F. Dupre, G. Body, and S. Giard
Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy for Advanced Breast Cancer: Results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French Prospective Multicentric Study
J. Clin. Oncol.,
February 10, 2009;
27(5):
726 - 732.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. H. Lyman, K. J. Van Zee, and S. B. Edge
Impact and Remaining Challenges in the Use of Sentinel Lymph Node Biopsy in Early-stage Breast Cancer
ASCO Educational Book,
January 1, 2009;
2009(1):
346 - 353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. M. van Deurzen, M. de Boer, E. M. Monninkhof, P. Bult, E. van der Wall, V. C. G. Tjan-Heijnen, and P. J. van Diest
Non-Sentinel Lymph Node Metastases Associated With Isolated Breast Cancer Cells in the Sentinel Node
J Natl Cancer Inst,
November 19, 2008;
100(22):
1574 - 1580.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Manca, A. Romanini, D. Pellegrino, E. Borso, M. Rondini, C. Orlandini, V. Zucchi, F. Pasqualetti, and G. Mariani
Optimal Detection of Sentinel Lymph Node Metastases by Intraoperative Radioactive Threshold and Molecular Analysis in Patients with Melanoma
J. Nucl. Med.,
November 1, 2008;
49(11):
1769 - 1775.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E L SENIOR, R SINNATAMBY, and R EATON
The chest X-ray black hole
Br. J. Radiol.,
August 1, 2008;
81(968):
677 - 678.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. D. Bear
Completion Axillary Lymph Node Dissection for Breast Cancer: Immediate Versus Delayed Versus None
J. Clin. Oncol.,
July 20, 2008;
26(21):
3483 - 3484.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. Olson Jr, L. M. McCall, P. Beitsch, P. W. Whitworth, D. S. Reintgen, P. W. Blumencranz, A. M. Leitch, S. Saha, K. K. Hunt, and A. E. Giuliano
Impact of Immediate Versus Delayed Axillary Node Dissection on Surgical Outcomes in Breast Cancer Patients With Positive Sentinel Nodes: Results From American College of Surgeons Oncology Group Trials Z0010 and Z0011
J. Clin. Oncol.,
July 20, 2008;
26(21):
3530 - 3535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Grube, C. J. Christy, D. Black, M. Martel, L. Harris, J. Weidhaas, M. P. DiGiovanna, G. Chung, M. M. Abu-Khalaf, K. D. Miller, et al.
Breast Sentinel Lymph Node Dissection Before Preoperative Chemotherapy
Arch Surg,
July 1, 2008;
143(7):
692 - 700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Y. Chen, M. T. Halpern, N. M. Schrag, A. Stewart, M. Leitch, and E. Ward
Disparities and Trends in Sentinel Lymph Node Biopsy Among Early-Stage Breast Cancer Patients (1998-2005)
J Natl Cancer Inst,
April 2, 2008;
100(7):
462 - 474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Edge
Early Adoption and Disturbing Disparities in Sentinel Node Biopsy in Breast Cancer
J Natl Cancer Inst,
April 2, 2008;
100(7):
449 - 450.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. J. Selman, C. Mann MD, J. Zamora PhD, T.-L. Appleyard MBBS, and K. Khan MSc
Diagnostic accuracy of tests for lymph node status in primary cervical cancer: a systematic review and meta-analysis
Can. Med. Assoc. J.,
March 25, 2008;
178(7):
855 - 862.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. J.T. Rutgers
Sentinel Node Biopsy: Interpretation and Management of Patients With Immunohistochemistry-Positive Sentinel Nodes and Those With Micrometastases
J. Clin. Oncol.,
February 10, 2008;
26(5):
698 - 702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. C. Hodgson and K. Y. Gulenchyn
Is There a Role for Positron Emission Tomography in Breast Cancer Staging?
J. Clin. Oncol.,
February 10, 2008;
26(5):
712 - 720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Somasundaram, D. W. Chicken, and M. R. S. Keshtgar
Detection of the sentinel lymph node in breast cancer
Br. Med. Bull.,
January 3, 2008;
(2008)
ldm032v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. MINIGH
Sentinel Lymph Node Mapping of the Breast
Radiol. Technol.,
January 1, 2008;
79(3):
243M - 257M.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kaufmann, G. von Minckwitz, H. D. Bear, A. Buzdar, P. McGale, H. Bonnefoi, M. Colleoni, C. Denkert, W. Eiermann, R. Jackesz, et al.
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006
Ann. Onc.,
December 1, 2007;
18(12):
1927 - 1934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Delpech, A. Cortez, C. Coutant, P. Callard, S. Uzan, E. Darai, and E. Barranger
The sentinel node concept in endometrial cancer: histopathologic validation by serial section and immunohistochemistry
Ann. Onc.,
November 1, 2007;
18(11):
1799 - 1803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Kuhl
Current Status of Breast MR Imaging * Part 2. Clinical Applications
Radiology,
September 1, 2007;
244(3):
672 - 691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tsujimoto, K. Nakabayashi, K. Yoshidome, T. Kaneko, T. Iwase, F. Akiyama, Y. Kato, H. Tsuda, S. Ueda, K. Sato, et al.
One-step Nucleic Acid Amplification for Intraoperative Detection of Lymph Node Metastasis in Breast Cancer Patients
Clin. Cancer Res.,
August 15, 2007;
13(16):
4807 - 4816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. P. Cronin-Fenton, L. A. Ries, L. X. Clegg, and B. K. Edwards
Rising Incidence Rates of Breast Carcinoma With Micrometastatic Lymph Node Involvement
J Natl Cancer Inst,
July 4, 2007;
99(13):
1044 - 1049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Chagpar, C. R. Scoggins, R. C. G. Martin II, D. J. Carlson, A. L. Laidley, S. E. El-Eid, T. Q. McGlothin, K. M. McMasters, and for the University of Louisville Breast Sentinel L
Are 3 Sentinel Nodes Sufficient?
Arch Surg,
May 1, 2007;
142(5):
456 - 460.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Gentilini, E. Chagas, S. Zurrida, M. Intra, C. De Cicco, G. Gatti, L. Silva, G. Renne, E. Cassano, and U. Veronesi
Sentinel Lymph Node Biopsy in Male Patients with Early Breast Cancer
Oncologist,
May 1, 2007;
12(5):
512 - 515.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Mathelin, S. Salvador, D. Huss, and J.-L. Guyonnet
Precise Localization of Sentinel Lymph Nodes and Estimation of Their Depth Using a Prototype Intraoperative Mini {gamma}-Camera in Patients with Breast Cancer
J. Nucl. Med.,
April 1, 2007;
48(4):
623 - 629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Balch and N. Cascinelli
Sentinel-Node Biopsy in Melanoma
N. Engl. J. Med.,
September 28, 2006;
355(13):
1370 - 1371.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Enger, S. S. Thwin, D. S.M. Buist, T. Field, F. Frost, A. M. Geiger, T. L. Lash, M. Prout, M. U. Yood, F. Wei, et al.
Breast Cancer Treatment of Older Women in Integrated Health Care Settings
J. Clin. Oncol.,
September 20, 2006;
24(27):
4377 - 4383.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Smyth
Rapid Determination of the Radiochemical Purity of 99mTc-Antimony Trisulfide Colloid Prepared by Standard and Alternative Heating Methods.
J. Nucl. Med. Technol.,
September 1, 2006;
34(3):
174 - 178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Chen, D. M. Iddings, R. P. Scheri, and A. J. Bilchik
Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications
CA Cancer J Clin,
September 1, 2006;
56(5):
292 - 309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chung, D. Liou, S. Karlan, A. Waxman, K. Fujimoto, M. Hagiike, and E. H. Phillips
Preoperative FDG-PET for Axillary Metastases in Patients With Breast Cancer
Arch Surg,
August 1, 2006;
141(8):
783 - 789.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Knauer, P. Konstantiniuk, A. Haid, E. Wenzl, M. Riegler-Keil, S. Postlberger, R. Reitsamer, and P. Schrenk
Multicentric Breast Cancer: A New Indication for Sentinel Node Biopsy--A Multi-Institutional Validation Study
J. Clin. Oncol.,
July 20, 2006;
24(21):
3374 - 3380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Pater and W. Parulekar
Sentinel lymph node biopsy in early breast cancer: has its time come?
J Natl Cancer Inst,
May 3, 2006;
98(9):
568 - 569.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Mansel, L. Fallowfield, M. Kissin, A. Goyal, R. G. Newcombe, J. M. Dixon, C. Yiangou, K. Horgan, N. Bundred, I. Monypenny, et al.
Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
J Natl Cancer Inst,
May 3, 2006;
98(9):
599 - 609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Carter and D. L. Page
Sentinel Lymph Node Histopathology in Breast Cancer: Minimal Disease Versus Artifact
J. Clin. Oncol.,
May 1, 2006;
24(13):
1978 - 1979.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. D. Bear
Sentinel Node Micrometastases and Non-Sentinel Nodes in Breast Cancer: How Much Do We Need to Know?
J. Clin. Oncol.,
April 20, 2006;
24(12):
1788 - 1790.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hemminki and P.-L. Kellokumpu-Lehtinen
Harmful impact of EU clinical trials directive.
BMJ,
March 4, 2006;
332(7540):
501 - 502.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Galimberti
International Breast Cancer Study Group Trial of Sentinel Node Biopsy
J. Clin. Oncol.,
January 1, 2006;
24(1):
210 - 211.
[Full Text]
[PDF]
|
 |
|
|